Overall, proteogenomic analysis revealed that the dual activation of PIK3CA at the genomic level and AKTs at the protein level may be a common signature of breast tumours, affecting more than 20% of PDXs in this cohort. This evidence concerns the gene PIK3CA and breast neoplasm.